Adrenal Tumors
7
1
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours
Adrenal Tumors - Pathogenesis and Therapy
Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Diagnosis of Indeterminate Adrenal Tumors on Conventional Imaging: A French Prospective Multicentric Study
Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)
Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation
Anesthesia Management of Retroperitoneal Adrenalectomies
Prospective Randonmized Comparison of Needlescopic Versus Conventional Laparoscopic Adrenalectomy